Literature DB >> 10196345

Immunization with potato plants expressing VP60 protein protects against rabbit hemorrhagic disease virus.

S Castañón1, M S Marín, J M Martín-Alonso, J A Boga, R Casais, J M Humara, R J Ordás, F Parra.   

Abstract

The major structural protein VP60 of rabbit hemorrhagic disease virus (RHDV) has been produced in transgenic potato plants under the control of a cauliflower mosaic virus 35S promoter or a modified 35S promoter that included two copies of a strong transcriptional enhancer. Both types of promoters allowed the production of specific mRNAs and detectable levels of recombinant VP60, which were higher for the constructs carrying the modified 35S promoter. Rabbits immunized with leaf extracts from plants carrying this modified 35S promoter showed high anti-VP60 antibody titers and were fully protected against the hemorrhagic disease.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10196345      PMCID： PMC104230     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  23 in total

1.  Expression of hepatitis B surface antigen in transgenic plants.

Authors:  H S Mason; D M Lam; C J Arntzen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

2.  Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice.

Authors:  H S Mason; J M Ball; J J Shi; X Jiang; M K Estes; C J Arntzen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

3.  Identification and characterization of the virus causing rabbit hemorrhagic disease.

Authors:  V F Ohlinger; B Haas; G Meyers; F Weiland; H J Thiel
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

4.  A single dose immunization with rabbit haemorrhagic disease virus major capsid protein produced in Saccharomyces cerevisiae induces protection.

Authors:  J A Boga; J M Martín Alonso; R Casais; F Parra
Journal:  J Gen Virol       Date:  1997-09       Impact factor: 3.891

5.  Programmed cell death in the pathogenesis of rabbit hemorrhagic disease.

Authors:  C Alonso; J M Oviedo; J M Martín-Alonso; E Díaz; J A Boga; F Parra
Journal:  Arch Virol       Date:  1998       Impact factor: 2.574

Review 6.  Viral haemorrhagic disease of rabbits: vaccination and immune response.

Authors:  J L Argüello Villares
Journal:  Rev Sci Tech       Date:  1991-06       Impact factor: 1.181

7.  Protection of rabbits against rabbit viral haemorrhagic disease with a vaccinia-RHDV recombinant virus.

Authors:  S Bertagnoli; J Gelfi; F Petit; J F Vautherot; D Rasschaert; S Laurent; G Le Gall; E Boilletot; J Chantal; C Boucraut-Baralon
Journal:  Vaccine       Date:  1996-04       Impact factor: 3.641

8.  Molecular cloning, sequencing and expression in Escherichia coli of the capsid protein gene from rabbit haemorrhagic disease virus (Spanish isolate AST/89).

Authors:  J A Boga; R Casais; M S Marin; J M Martin-Alonso; R S Carmenes; M Prieto; F Parra
Journal:  J Gen Virol       Date:  1994-09       Impact factor: 3.891

9.  The effects of promoter on transient expression in conifer cell lines.

Authors:  F Bekkaoui; R S Datla; M Pilon; T E Tautorus; W L Crosby; D I Dunstan
Journal:  Theor Appl Genet       Date:  1990-05       Impact factor: 5.699

10.  Oral immunization with a recombinant bacterial antigen produced in transgenic plants.

Authors:  T A Haq; H S Mason; J D Clements; C J Arntzen
Journal:  Science       Date:  1995-05-05       Impact factor: 47.728
View more
  28 in total

1.  Strict Assembly Restriction of Peptides from Rabbit Hemorrhagic Disease Virus Presented by Rabbit Major Histocompatibility Complex Class I Molecule RLA-A1.

Authors:  Qingxu Zhang; Kefang Liu; Can Yue; Di Zhang; Dan Lu; Wenling Xiao; Peipei Liu; Yingze Zhao; Guolan Gao; Chunming Ding; Jianxin Lyu; William J Liu
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

2.  Horizontal transmissible protection against myxomatosis and rabbit hemorrhagic disease by using a recombinant myxoma virus.

Authors:  J Bárcena; M Morales; B Vázquez; J A Boga; F Parra; J Lucientes; A Pagès-Manté; J M Sánchez-Vizcaíno; R Blasco; J M Torres
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Cloning of Helicobacter pylori urease subunit B gene and its expression in tobacco (Nicotiana tabacum L.).

Authors:  Qing Gu; Ning Han; Jianyi Liu; Muyuan Zhu
Journal:  Plant Cell Rep       Date:  2005-08-26       Impact factor: 4.570

4.  Tobacco as biofactory for biologically active hPL production: a human hormone with potential applications in type-1 diabetes.

Authors:  Iratxe Urreta; Iñigo Oyanguren; Sonia Castañón
Journal:  Transgenic Res       Date:  2010-10-20       Impact factor: 2.788

5.  Greenhouse and field cultivations of antigen-expressing potatoes focusing on the variability in plant constituents and antigen expression.

Authors:  Heike Mikschofsky; Elena Heilmann; Jörg Schmidtke; Kerstin Schmidt; Udo Meyer; Peter Leinweber; Inge Broer
Journal:  Plant Mol Biol       Date:  2011-04-05       Impact factor: 4.076

6.  Expression of immunogenic S1 glycoprotein of infectious bronchitis virus in transgenic potatoes.

Authors:  Ji-Yong Zhou; Jian-Xiang Wu; Li-Qin Cheng; Xiao-Juan Zheng; Hui Gong; Shao-Bin Shang; En-Min Zhou
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

7.  Targeted expression of human serum albumin to potato tubers.

Authors:  Inma Farran; José J Sánchez-Serrano; Juan F Medina; Jesús Prieto; Angel M Mingo-Castel
Journal:  Transgenic Res       Date:  2002-08       Impact factor: 2.788

8.  Puumala virus nucleocapsid protein expressed in transgenic plants is not immunogenic after oral administration.

Authors:  Shahryar Khattak; Gholamreza Darai; Angela Rösen-Wolff
Journal:  Virus Genes       Date:  2004-08       Impact factor: 2.332

9.  Oral immunization using tuber extracts from transgenic potato plants expressing rabbit hemorrhagic disease virus capsid protein.

Authors:  José M Martín-Alonso; Sonia Castañón; Pablo Alonso; Francisco Parra; Ricardo Ordás
Journal:  Transgenic Res       Date:  2003-02       Impact factor: 2.788

10.  Conformational and thermal stability improvements for the large-scale production of yeast-derived rabbit hemorrhagic disease virus-like particles as multipurpose vaccine.

Authors:  Erlinda Fernández; Jorge R Toledo; Lídice Méndez; Nemecio González; Francisco Parra; José M Martín-Alonso; Miladys Limonta; Kosara Sánchez; Ania Cabrales; Mario P Estrada; Alina Rodríguez-Mallón; Omar Farnós
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.